nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—CHRM3—nephrolithiasis	0.696	1	CbGaD
Aripiprazole—Panic disorder—Hydrochlorothiazide—nephrolithiasis	0.00918	0.0645	CcSEcCtD
Aripiprazole—CHRM3—ureter—nephrolithiasis	0.00782	0.236	CbGeAlD
Aripiprazole—Abnormal faeces—Hydrochlorothiazide—nephrolithiasis	0.0037	0.026	CcSEcCtD
Aripiprazole—Blood potassium increased—Hydrochlorothiazide—nephrolithiasis	0.0035	0.0246	CcSEcCtD
Aripiprazole—Cardiac murmur—Hydrochlorothiazide—nephrolithiasis	0.00341	0.024	CcSEcCtD
Aripiprazole—Local swelling—Hydrochlorothiazide—nephrolithiasis	0.00303	0.0213	CcSEcCtD
Aripiprazole—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.00303	0.0213	CcSEcCtD
Aripiprazole—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.00278	0.0196	CcSEcCtD
Aripiprazole—Ziprasidone—CHRM3—nephrolithiasis	0.00231	1	CrCbGaD
Aripiprazole—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.00216	0.0152	CcSEcCtD
Aripiprazole—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00201	0.0141	CcSEcCtD
Aripiprazole—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00189	0.0133	CcSEcCtD
Aripiprazole—Toothache—Hydrochlorothiazide—nephrolithiasis	0.00174	0.0122	CcSEcCtD
Aripiprazole—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.00167	0.0117	CcSEcCtD
Aripiprazole—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.00158	0.0111	CcSEcCtD
Aripiprazole—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00154	0.0108	CcSEcCtD
Aripiprazole—HTR2A—urine—nephrolithiasis	0.00151	0.0455	CbGeAlD
Aripiprazole—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.00147	0.0103	CcSEcCtD
Aripiprazole—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00143	0.01	CcSEcCtD
Aripiprazole—CYP3A4—urine—nephrolithiasis	0.0014	0.0422	CbGeAlD
Aripiprazole—CYP2D6—urine—nephrolithiasis	0.00137	0.0415	CbGeAlD
Aripiprazole—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.00135	0.00947	CcSEcCtD
Aripiprazole—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.00135	0.00947	CcSEcCtD
Aripiprazole—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00131	0.00918	CcSEcCtD
Aripiprazole—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00129	0.00904	CcSEcCtD
Aripiprazole—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.00121	0.0365	CbGeAlD
Aripiprazole—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0012	0.0084	CcSEcCtD
Aripiprazole—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00118	0.00829	CcSEcCtD
Aripiprazole—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00117	0.00823	CcSEcCtD
Aripiprazole—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00114	0.00801	CcSEcCtD
Aripiprazole—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00114	0.00801	CcSEcCtD
Aripiprazole—Gout—Hydrochlorothiazide—nephrolithiasis	0.00113	0.00796	CcSEcCtD
Aripiprazole—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00112	0.00786	CcSEcCtD
Aripiprazole—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0011	0.00776	CcSEcCtD
Aripiprazole—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00757	CcSEcCtD
Aripiprazole—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00757	CcSEcCtD
Aripiprazole—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00107	0.00752	CcSEcCtD
Aripiprazole—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00106	0.00743	CcSEcCtD
Aripiprazole—H1F0—nephron tubule—nephrolithiasis	0.00106	0.0319	CbGeAlD
Aripiprazole—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00104	0.0073	CcSEcCtD
Aripiprazole—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00104	0.0313	CbGeAlD
Aripiprazole—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00722	CcSEcCtD
Aripiprazole—ADRA1B—renal system—nephrolithiasis	0.00102	0.0307	CbGeAlD
Aripiprazole—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.000999	0.00702	CcSEcCtD
Aripiprazole—ADRA1B—kidney—nephrolithiasis	0.000982	0.0297	CbGeAlD
Aripiprazole—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.000967	0.00679	CcSEcCtD
Aripiprazole—H1F0—renal system—nephrolithiasis	0.000959	0.029	CbGeAlD
Aripiprazole—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.000957	0.00672	CcSEcCtD
Aripiprazole—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.000957	0.00672	CcSEcCtD
Aripiprazole—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.000942	0.00662	CcSEcCtD
Aripiprazole—H1F0—kidney—nephrolithiasis	0.000927	0.028	CbGeAlD
Aripiprazole—H1F0—cortex of kidney—nephrolithiasis	0.000903	0.0273	CbGeAlD
Aripiprazole—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.000887	0.00623	CcSEcCtD
Aripiprazole—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.000883	0.0062	CcSEcCtD
Aripiprazole—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.000875	0.00615	CcSEcCtD
Aripiprazole—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.000875	0.00615	CcSEcCtD
Aripiprazole—Swelling—Hydrochlorothiazide—nephrolithiasis	0.000871	0.00612	CcSEcCtD
Aripiprazole—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.000866	0.00609	CcSEcCtD
Aripiprazole—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.000843	0.00592	CcSEcCtD
Aripiprazole—Injury—Hydrochlorothiazide—nephrolithiasis	0.000836	0.00587	CcSEcCtD
Aripiprazole—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.000828	0.00582	CcSEcCtD
Aripiprazole—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.000821	0.00577	CcSEcCtD
Aripiprazole—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.000817	0.00574	CcSEcCtD
Aripiprazole—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.000814	0.00572	CcSEcCtD
Aripiprazole—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.000814	0.00572	CcSEcCtD
Aripiprazole—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00081	0.00569	CcSEcCtD
Aripiprazole—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00081	0.00569	CcSEcCtD
Aripiprazole—Thirst—Hydrochlorothiazide—nephrolithiasis	0.000807	0.00567	CcSEcCtD
Aripiprazole—Purpura—Hydrochlorothiazide—nephrolithiasis	0.000797	0.0056	CcSEcCtD
Aripiprazole—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00079	0.00555	CcSEcCtD
Aripiprazole—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.000771	0.00542	CcSEcCtD
Aripiprazole—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.000768	0.0054	CcSEcCtD
Aripiprazole—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.000768	0.0054	CcSEcCtD
Aripiprazole—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.000762	0.00535	CcSEcCtD
Aripiprazole—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.000756	0.00531	CcSEcCtD
Aripiprazole—Migraine—Hydrochlorothiazide—nephrolithiasis	0.000756	0.00531	CcSEcCtD
Aripiprazole—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.000741	0.00521	CcSEcCtD
Aripiprazole—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.000728	0.00511	CcSEcCtD
Aripiprazole—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.000722	0.00507	CcSEcCtD
Aripiprazole—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.000719	0.00506	CcSEcCtD
Aripiprazole—HTR1D—kidney—nephrolithiasis	0.000718	0.0217	CbGeAlD
Aripiprazole—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.000709	0.00498	CcSEcCtD
Aripiprazole—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.000704	0.00495	CcSEcCtD
Aripiprazole—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.000701	0.00493	CcSEcCtD
Aripiprazole—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.000701	0.00493	CcSEcCtD
Aripiprazole—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.000699	0.00491	CcSEcCtD
Aripiprazole—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.000694	0.00488	CcSEcCtD
Aripiprazole—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.000692	0.00486	CcSEcCtD
Aripiprazole—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000692	0.00486	CcSEcCtD
Aripiprazole—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00068	0.00478	CcSEcCtD
Aripiprazole—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000677	0.00476	CcSEcCtD
Aripiprazole—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.000677	0.00476	CcSEcCtD
Aripiprazole—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.000668	0.0047	CcSEcCtD
Aripiprazole—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.000664	0.00466	CcSEcCtD
Aripiprazole—Influenza—Hydrochlorothiazide—nephrolithiasis	0.000664	0.00466	CcSEcCtD
Aripiprazole—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.000651	0.00457	CcSEcCtD
Aripiprazole—HTR2B—cortex of kidney—nephrolithiasis	0.000651	0.0196	CbGeAlD
Aripiprazole—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.000647	0.00454	CcSEcCtD
Aripiprazole—CHRM3—renal system—nephrolithiasis	0.000622	0.0188	CbGeAlD
Aripiprazole—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000621	0.00436	CcSEcCtD
Aripiprazole—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.000621	0.00436	CcSEcCtD
Aripiprazole—HTR1A—renal system—nephrolithiasis	0.000619	0.0187	CbGeAlD
Aripiprazole—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.000617	0.00433	CcSEcCtD
Aripiprazole—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.000613	0.00431	CcSEcCtD
Aripiprazole—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.000611	0.0043	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.000606	0.00426	CcSEcCtD
Aripiprazole—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.000604	0.00424	CcSEcCtD
Aripiprazole—CHRM3—kidney—nephrolithiasis	0.000601	0.0181	CbGeAlD
Aripiprazole—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000599	0.00421	CcSEcCtD
Aripiprazole—ADRA2C—nephron tubule—nephrolithiasis	0.000598	0.0181	CbGeAlD
Aripiprazole—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.000595	0.00418	CcSEcCtD
Aripiprazole—HTR7—renal system—nephrolithiasis	0.000592	0.0179	CbGeAlD
Aripiprazole—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.000583	0.0041	CcSEcCtD
Aripiprazole—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.000582	0.00409	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00058	0.00408	CcSEcCtD
Aripiprazole—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00058	0.00408	CcSEcCtD
Aripiprazole—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.000577	0.00405	CcSEcCtD
Aripiprazole—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.000575	0.00404	CcSEcCtD
Aripiprazole—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.000575	0.00404	CcSEcCtD
Aripiprazole—HTR7—kidney—nephrolithiasis	0.000572	0.0173	CbGeAlD
Aripiprazole—ADRA1A—renal system—nephrolithiasis	0.000571	0.0172	CbGeAlD
Aripiprazole—Sweating—Hydrochlorothiazide—nephrolithiasis	0.000567	0.00399	CcSEcCtD
Aripiprazole—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.000564	0.00397	CcSEcCtD
Aripiprazole—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.000558	0.00392	CcSEcCtD
Aripiprazole—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.000555	0.0039	CcSEcCtD
Aripiprazole—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.000552	0.00388	CcSEcCtD
Aripiprazole—KCNH2—renal system—nephrolithiasis	0.000551	0.0166	CbGeAlD
Aripiprazole—ADRA2C—renal system—nephrolithiasis	0.000544	0.0164	CbGeAlD
Aripiprazole—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.000541	0.0038	CcSEcCtD
Aripiprazole—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.000533	0.00374	CcSEcCtD
Aripiprazole—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.000531	0.00373	CcSEcCtD
Aripiprazole—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.000529	0.00371	CcSEcCtD
Aripiprazole—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.000527	0.00371	CcSEcCtD
Aripiprazole—ADRA2C—kidney—nephrolithiasis	0.000526	0.0159	CbGeAlD
Aripiprazole—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.000523	0.00368	CcSEcCtD
Aripiprazole—ADRA2C—cortex of kidney—nephrolithiasis	0.000512	0.0155	CbGeAlD
Aripiprazole—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.000512	0.0036	CcSEcCtD
Aripiprazole—CYP3A5—nephron tubule—nephrolithiasis	0.000501	0.0151	CbGeAlD
Aripiprazole—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000495	0.00348	CcSEcCtD
Aripiprazole—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000493	0.00346	CcSEcCtD
Aripiprazole—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.000469	0.0033	CcSEcCtD
Aripiprazole—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000462	0.00325	CcSEcCtD
Aripiprazole—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000456	0.0032	CcSEcCtD
Aripiprazole—CYP3A5—renal system—nephrolithiasis	0.000455	0.0137	CbGeAlD
Aripiprazole—Tension—Hydrochlorothiazide—nephrolithiasis	0.000454	0.00319	CcSEcCtD
Aripiprazole—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000453	0.00318	CcSEcCtD
Aripiprazole—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000449	0.00316	CcSEcCtD
Aripiprazole—Back pain—Hydrochlorothiazide—nephrolithiasis	0.000447	0.00314	CcSEcCtD
Aripiprazole—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000445	0.00312	CcSEcCtD
Aripiprazole—CYP3A5—kidney—nephrolithiasis	0.00044	0.0133	CbGeAlD
Aripiprazole—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000436	0.00306	CcSEcCtD
Aripiprazole—Tremor—Hydrochlorothiazide—nephrolithiasis	0.000433	0.00304	CcSEcCtD
Aripiprazole—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000429	0.00302	CcSEcCtD
Aripiprazole—CYP3A5—cortex of kidney—nephrolithiasis	0.000429	0.0129	CbGeAlD
Aripiprazole—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.000427	0.003	CcSEcCtD
Aripiprazole—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000425	0.00299	CcSEcCtD
Aripiprazole—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.000423	0.00297	CcSEcCtD
Aripiprazole—Malaise—Hydrochlorothiazide—nephrolithiasis	0.000417	0.00293	CcSEcCtD
Aripiprazole—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000416	0.00292	CcSEcCtD
Aripiprazole—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000415	0.00291	CcSEcCtD
Aripiprazole—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000414	0.00291	CcSEcCtD
Aripiprazole—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000409	0.00287	CcSEcCtD
Aripiprazole—ADRA2A—cortex of kidney—nephrolithiasis	0.000409	0.0123	CbGeAlD
Aripiprazole—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000406	0.00286	CcSEcCtD
Aripiprazole—Cough—Hydrochlorothiazide—nephrolithiasis	0.000404	0.00284	CcSEcCtD
Aripiprazole—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000394	0.00277	CcSEcCtD
Aripiprazole—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000394	0.00277	CcSEcCtD
Aripiprazole—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000394	0.00277	CcSEcCtD
Aripiprazole—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000392	0.00276	CcSEcCtD
Aripiprazole—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000389	0.00273	CcSEcCtD
Aripiprazole—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000385	0.00271	CcSEcCtD
Aripiprazole—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000381	0.00267	CcSEcCtD
Aripiprazole—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000377	0.00265	CcSEcCtD
Aripiprazole—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000377	0.00265	CcSEcCtD
Aripiprazole—Shock—Hydrochlorothiazide—nephrolithiasis	0.000371	0.00261	CcSEcCtD
Aripiprazole—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00037	0.0026	CcSEcCtD
Aripiprazole—HTR2A—renal system—nephrolithiasis	0.000369	0.0111	CbGeAlD
Aripiprazole—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000368	0.00259	CcSEcCtD
Aripiprazole—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000365	0.00256	CcSEcCtD
Aripiprazole—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00036	0.00253	CcSEcCtD
Aripiprazole—HTR2A—kidney—nephrolithiasis	0.000357	0.0108	CbGeAlD
Aripiprazole—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000353	0.00248	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000344	0.00242	CcSEcCtD
Aripiprazole—CYP3A4—renal system—nephrolithiasis	0.000342	0.0103	CbGeAlD
Aripiprazole—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000341	0.0024	CcSEcCtD
Aripiprazole—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000339	0.00238	CcSEcCtD
Aripiprazole—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000337	0.00236	CcSEcCtD
Aripiprazole—CYP2D6—renal system—nephrolithiasis	0.000336	0.0102	CbGeAlD
Aripiprazole—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000336	0.00236	CcSEcCtD
Aripiprazole—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000332	0.00233	CcSEcCtD
Aripiprazole—CYP3A4—kidney—nephrolithiasis	0.00033	0.00997	CbGeAlD
Aripiprazole—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000328	0.00231	CcSEcCtD
Aripiprazole—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000325	0.00229	CcSEcCtD
Aripiprazole—CYP2D6—kidney—nephrolithiasis	0.000325	0.00981	CbGeAlD
Aripiprazole—Pain—Hydrochlorothiazide—nephrolithiasis	0.000323	0.00227	CcSEcCtD
Aripiprazole—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000323	0.00227	CcSEcCtD
Aripiprazole—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000311	0.00219	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000309	0.00217	CcSEcCtD
Aripiprazole—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.0003	0.00211	CcSEcCtD
Aripiprazole—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000298	0.0021	CcSEcCtD
Aripiprazole—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000298	0.0021	CcSEcCtD
Aripiprazole—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000278	0.00195	CcSEcCtD
Aripiprazole—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000271	0.0019	CcSEcCtD
Aripiprazole—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000267	0.00188	CcSEcCtD
Aripiprazole—ABCB1—nephron tubule—nephrolithiasis	0.000266	0.00803	CbGeAlD
Aripiprazole—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000258	0.00181	CcSEcCtD
Aripiprazole—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00025	0.00175	CcSEcCtD
Aripiprazole—ABCB1—renal system—nephrolithiasis	0.000242	0.0073	CbGeAlD
Aripiprazole—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00024	0.00169	CcSEcCtD
Aripiprazole—Rash—Hydrochlorothiazide—nephrolithiasis	0.000238	0.00167	CcSEcCtD
Aripiprazole—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000238	0.00167	CcSEcCtD
Aripiprazole—Headache—Hydrochlorothiazide—nephrolithiasis	0.000236	0.00166	CcSEcCtD
Aripiprazole—ABCB1—kidney—nephrolithiasis	0.000234	0.00706	CbGeAlD
Aripiprazole—ABCB1—cortex of kidney—nephrolithiasis	0.000228	0.00687	CbGeAlD
Aripiprazole—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000224	0.00158	CcSEcCtD
Aripiprazole—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	5.73e-05	0.000453	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	5.71e-05	0.000451	CbGpPWpGaD
Aripiprazole—DRD4—Signaling by GPCR—PTH—nephrolithiasis	5.69e-05	0.00045	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	5.65e-05	0.000447	CbGpPWpGaD
Aripiprazole—DRD1—GPCR downstream signaling—PTH—nephrolithiasis	5.64e-05	0.000446	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—RGS14—nephrolithiasis	5.64e-05	0.000446	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	5.64e-05	0.000446	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—CHRM3—nephrolithiasis	5.63e-05	0.000445	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—PTH—nephrolithiasis	5.62e-05	0.000444	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—CHRM3—nephrolithiasis	5.6e-05	0.000443	CbGpPWpGaD
Aripiprazole—DRD3—GPCR downstream signaling—PTH—nephrolithiasis	5.57e-05	0.00044	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	5.55e-05	0.000439	CbGpPWpGaD
Aripiprazole—ADRB1—GPCR downstream signaling—CHRM3—nephrolithiasis	5.55e-05	0.000438	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—CHRM3—nephrolithiasis	5.53e-05	0.000437	CbGpPWpGaD
Aripiprazole—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	5.5e-05	0.000434	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—GRHPR—nephrolithiasis	5.48e-05	0.000433	CbGpPWpGaD
Aripiprazole—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	5.46e-05	0.000432	CbGpPWpGaD
Aripiprazole—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	5.46e-05	0.000432	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—PTH—nephrolithiasis	5.43e-05	0.000429	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	5.39e-05	0.000426	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	5.38e-05	0.000425	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AGXT—nephrolithiasis	5.32e-05	0.000421	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.32e-05	0.00042	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—DGKH—nephrolithiasis	5.32e-05	0.00042	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.31e-05	0.00042	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—DGKH—nephrolithiasis	5.31e-05	0.00042	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	5.31e-05	0.000419	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	5.28e-05	0.000417	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.28e-05	0.000417	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—DGKH—nephrolithiasis	5.28e-05	0.000417	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	5.26e-05	0.000416	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—APRT—nephrolithiasis	5.26e-05	0.000416	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	5.24e-05	0.000414	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—DGKH—nephrolithiasis	5.17e-05	0.000408	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.17e-05	0.000408	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—PTH—nephrolithiasis	5.15e-05	0.000407	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—CHRM3—nephrolithiasis	5.13e-05	0.000406	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—PTH—nephrolithiasis	5.12e-05	0.000405	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—RGS14—nephrolithiasis	5.12e-05	0.000404	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—SLC26A1—nephrolithiasis	5.11e-05	0.000404	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—APRT—nephrolithiasis	5.11e-05	0.000404	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.09e-05	0.000402	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—DGKH—nephrolithiasis	5.09e-05	0.000402	CbGpPWpGaD
Aripiprazole—ADRB1—GPCR downstream signaling—PTH—nephrolithiasis	5.07e-05	0.000401	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—PTH—nephrolithiasis	5.06e-05	0.0004	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	5.05e-05	0.000399	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—CHRM3—nephrolithiasis	5.04e-05	0.000398	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	5.04e-05	0.000398	CbGpPWpGaD
Aripiprazole—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	5.03e-05	0.000397	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—RGS14—nephrolithiasis	5.02e-05	0.000397	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—GRHPR—nephrolithiasis	5.02e-05	0.000397	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—DGKH—nephrolithiasis	5.02e-05	0.000396	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.02e-05	0.000396	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	5.01e-05	0.000396	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	4.99e-05	0.000395	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	4.99e-05	0.000394	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—CHRM3—nephrolithiasis	4.98e-05	0.000394	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	4.94e-05	0.000391	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	4.93e-05	0.00039	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AGXT—nephrolithiasis	4.88e-05	0.000386	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—DGKH—nephrolithiasis	4.85e-05	0.000384	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.85e-05	0.000384	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	4.85e-05	0.000384	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	4.83e-05	0.000382	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	4.82e-05	0.000381	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.8e-05	0.00038	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	4.8e-05	0.00038	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	4.79e-05	0.000379	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—PTH—nephrolithiasis	4.7e-05	0.000371	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—CHRM3—nephrolithiasis	4.66e-05	0.000368	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	4.66e-05	0.000368	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	4.62e-05	0.000365	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—PTH—nephrolithiasis	4.61e-05	0.000364	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	4.59e-05	0.000363	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	4.58e-05	0.000362	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	4.58e-05	0.000362	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—DGKH—nephrolithiasis	4.58e-05	0.000362	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.58e-05	0.000362	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	4.57e-05	0.000361	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	4.56e-05	0.000361	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	4.56e-05	0.00036	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—PTH—nephrolithiasis	4.56e-05	0.00036	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—APRT—nephrolithiasis	4.52e-05	0.000358	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—SLC26A1—nephrolithiasis	4.52e-05	0.000358	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—DGKH—nephrolithiasis	4.52e-05	0.000357	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.52e-05	0.000357	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	4.5e-05	0.000356	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	4.49e-05	0.000355	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AGXT—nephrolithiasis	4.47e-05	0.000354	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	4.41e-05	0.000348	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	4.38e-05	0.000346	CbGpPWpGaD
Aripiprazole—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	4.37e-05	0.000345	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—PTH—nephrolithiasis	4.26e-05	0.000337	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	4.26e-05	0.000337	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	4.23e-05	0.000334	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	4.2e-05	0.000332	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	4.19e-05	0.000331	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	4.18e-05	0.000331	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	4.17e-05	0.00033	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	4.17e-05	0.00033	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	4.16e-05	0.000329	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	4.16e-05	0.000328	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	4.15e-05	0.000328	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	4.15e-05	0.000328	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—APRT—nephrolithiasis	4.15e-05	0.000328	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	4.14e-05	0.000327	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	4.12e-05	0.000325	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—DGKH—nephrolithiasis	4.12e-05	0.000325	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.12e-05	0.000325	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	4.1e-05	0.000324	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	4.09e-05	0.000323	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	4.08e-05	0.000322	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.08e-05	0.000322	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	4.08e-05	0.000322	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.94e-05	0.000311	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	3.94e-05	0.000311	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	3.92e-05	0.00031	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.92e-05	0.00031	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—PTH—nephrolithiasis	3.87e-05	0.000306	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—CHRM3—nephrolithiasis	3.85e-05	0.000304	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—CHRM3—nephrolithiasis	3.84e-05	0.000304	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—CHRM3—nephrolithiasis	3.82e-05	0.000302	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	3.81e-05	0.000301	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.81e-05	0.000301	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—DGKH—nephrolithiasis	3.81e-05	0.000301	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	3.81e-05	0.000301	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	3.8e-05	0.000301	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—APRT—nephrolithiasis	3.8e-05	0.000301	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—PTH—nephrolithiasis	3.8e-05	0.0003	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—GRHPR—nephrolithiasis	3.79e-05	0.000299	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	3.79e-05	0.000299	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	3.79e-05	0.000299	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	3.77e-05	0.000298	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—AQP1—nephrolithiasis	3.75e-05	0.000296	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.75e-05	0.000296	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	3.75e-05	0.000296	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	3.74e-05	0.000295	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—CHRM3—nephrolithiasis	3.74e-05	0.000295	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	3.73e-05	0.000295	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—CHRM3—nephrolithiasis	3.68e-05	0.000291	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—AQP1—nephrolithiasis	3.64e-05	0.000288	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—CHRM3—nephrolithiasis	3.63e-05	0.000287	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—GRHPR—nephrolithiasis	3.57e-05	0.000282	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—PTH—nephrolithiasis	3.52e-05	0.000278	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—PTH—nephrolithiasis	3.51e-05	0.000278	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—CHRM3—nephrolithiasis	3.51e-05	0.000277	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—PTH—nephrolithiasis	3.49e-05	0.000276	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	3.47e-05	0.000275	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	3.46e-05	0.000274	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.46e-05	0.000273	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—DGKH—nephrolithiasis	3.46e-05	0.000273	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—PTH—nephrolithiasis	3.42e-05	0.00027	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.4e-05	0.000269	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	3.4e-05	0.000269	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.39e-05	0.000268	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—DGKH—nephrolithiasis	3.39e-05	0.000268	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—CHRM3—nephrolithiasis	3.39e-05	0.000268	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	3.38e-05	0.000267	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.38e-05	0.000267	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AGXT—nephrolithiasis	3.38e-05	0.000267	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	3.37e-05	0.000266	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.37e-05	0.000266	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—PTH—nephrolithiasis	3.36e-05	0.000266	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.34e-05	0.000264	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	3.34e-05	0.000264	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.33e-05	0.000263	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	3.33e-05	0.000263	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—PTH—nephrolithiasis	3.32e-05	0.000262	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CHRM3—nephrolithiasis	3.31e-05	0.000262	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—CHRM3—nephrolithiasis	3.29e-05	0.00026	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CHRM3—nephrolithiasis	3.27e-05	0.000258	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AQP1—nephrolithiasis	3.22e-05	0.000255	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—PTH—nephrolithiasis	3.21e-05	0.000254	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AGXT—nephrolithiasis	3.18e-05	0.000251	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—PTH—nephrolithiasis	3.18e-05	0.000251	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.09e-05	0.000245	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	3.09e-05	0.000245	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—PTH—nephrolithiasis	3.03e-05	0.000239	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—PTH—nephrolithiasis	2.99e-05	0.000236	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CHRM3—nephrolithiasis	2.98e-05	0.000235	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AQP1—nephrolithiasis	2.96e-05	0.000234	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	2.95e-05	0.000233	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—APRT—nephrolithiasis	2.87e-05	0.000227	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—SLC26A1—nephrolithiasis	2.87e-05	0.000227	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	2.85e-05	0.000225	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	2.83e-05	0.000224	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CHRM3—nephrolithiasis	2.75e-05	0.000218	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—PTH—nephrolithiasis	2.72e-05	0.000215	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AQP1—nephrolithiasis	2.71e-05	0.000214	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	2.71e-05	0.000214	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APRT—nephrolithiasis	2.71e-05	0.000214	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	2.71e-05	0.000214	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	2.7e-05	0.000213	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—CHRM3—nephrolithiasis	2.68e-05	0.000211	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—PTH—nephrolithiasis	2.6e-05	0.000206	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—PTH—nephrolithiasis	2.59e-05	0.000205	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—SPP1—nephrolithiasis	2.58e-05	0.000204	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—PTH—nephrolithiasis	2.52e-05	0.000199	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	2.5e-05	0.000197	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	2.48e-05	0.000196	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	2.46e-05	0.000194	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	2.45e-05	0.000194	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—CHRM3—nephrolithiasis	2.45e-05	0.000194	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	2.45e-05	0.000193	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	2.41e-05	0.000191	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	2.41e-05	0.00019	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GRHPR—nephrolithiasis	2.33e-05	0.000184	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—SPP1—nephrolithiasis	2.29e-05	0.000181	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PTH—nephrolithiasis	2.29e-05	0.000181	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PTH—nephrolithiasis	2.25e-05	0.000178	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PTH—nephrolithiasis	2.24e-05	0.000177	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	2.24e-05	0.000177	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PTH—nephrolithiasis	2.24e-05	0.000177	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PTH—nephrolithiasis	2.23e-05	0.000176	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PTH—nephrolithiasis	2.21e-05	0.000175	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	2.2e-05	0.000174	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AGXT—nephrolithiasis	2.08e-05	0.000164	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	2.05e-05	0.000162	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AQP1—nephrolithiasis	2.05e-05	0.000162	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AQP1—nephrolithiasis	1.93e-05	0.000152	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CHRM3—nephrolithiasis	1.85e-05	0.000146	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APRT—nephrolithiasis	1.77e-05	0.00014	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	1.77e-05	0.00014	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—SPP1—nephrolithiasis	1.77e-05	0.00014	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—SPP1—nephrolithiasis	1.76e-05	0.000139	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—SPP1—nephrolithiasis	1.75e-05	0.000138	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CHRM3—nephrolithiasis	1.74e-05	0.000138	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—SPP1—nephrolithiasis	1.72e-05	0.000136	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—SPP1—nephrolithiasis	1.69e-05	0.000133	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—SPP1—nephrolithiasis	1.67e-05	0.000132	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—SPP1—nephrolithiasis	1.61e-05	0.000127	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	1.59e-05	0.000126	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—SPP1—nephrolithiasis	1.52e-05	0.00012	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—SPP1—nephrolithiasis	1.5e-05	0.000119	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—SPP1—nephrolithiasis	1.37e-05	0.000108	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	1.35e-05	0.000107	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	1.31e-05	0.000103	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	1.3e-05	0.000103	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—SPP1—nephrolithiasis	1.26e-05	9.99e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AQP1—nephrolithiasis	1.26e-05	9.96e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	1.24e-05	9.84e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—SPP1—nephrolithiasis	1.15e-05	9.07e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CHRM3—nephrolithiasis	1.14e-05	9.01e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	1.13e-05	8.92e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—SPP1—nephrolithiasis	1.13e-05	8.9e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	1.12e-05	8.87e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	1.12e-05	8.85e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	1.11e-05	8.76e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	1.11e-05	8.74e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	1.03e-05	8.12e-05	CbGpPWpGaD
